1. Home
  2. DXR

as 07-25-2025 11:32am EST

$
-
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Medical/Dental Instruments

Nasdaq

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.

Founded: 1970 Country:
United States
United States
Employees: N/A City: NEW YORK
Market Cap: 46.1M IPO Year: N/A
Target Price: $25.00 AVG Volume (30 days): 3.5K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 0.11 EPS Growth: 86.16
52 Week Low/High: $6.55 - $10.00 Next Earning Date: 01-01-0001
Revenue: $119,714 Revenue Growth: -26.75%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

DXR Daily Stock ML Predictions

Share on Social Networks: